KSC Equity Snapshot
011000 Weekly Equity Report
GeneOne Life Science, Inc.
What the company does
GeneOne Life Science, Inc., a biopharmaceutical company, engages in the research, development, and contract manufacturing of nucleic acid-based biopharmaceuticals. Its small molecule pipeline comprises GLS-1027, which is in Phase I clinical trial for treatment of nephropathy and inflammatory diseases; GLS-1200 that is in Phase II clinical trial to treat Rhinosinusitis; GLS-1027 and GLS-1200, which is Phase II clinical trial for treatment of COVID-19. The company's nucleic acid vaccines include GLS-3000 mRNA under feasible study and GLS-5310 DNA under phase 2 stage for the treatment of SARS-CoV-2; GLS-5100 under pre-clinical stage for prevention of herpes zoster; …
What the weekly tape is saying
011000 closed the latest completed week at 918.0 KRW. The 4-week return is -4.4% and the 12-week return is -11.4%. Trend Signal is inactive, Market Dynamics is 0.69. Setup signature: Risk-first tape with a 23/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1,432 KRW
- Vs Trend Line
- -35.9%
- Fair Value
- 2,416 KRW
- Vs Fair Value
- -62.0%
- 52W High
- 3,000 KRW
- 52W Low
- 618.0 KRW
- Drawdown
- -69.4%
- Range Position
- 12.6%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 8
- 52W Active Breadth
- 15.4%
- Sector Scope
- KR Healthcare
- Sector Rank
- 61 of 63
- Sector Percentile
- 3.2%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 10 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Biotechnology
- Tracked Peers
- 10
- 4W Rank
- 2 of 10
- Avg 1W
- -0.9%
- Avg 4W
- -11.2%
- Trend Breadth
- 0.0%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.69
- 4W MD Change
- 370.3%
- Relative Strength
- -75.11
- 4W RS Change
- 1.1%
- Expectation
- Negative
- Probability
- 34.40%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 8.2M
- 13W Average
- 35.3M
- 52W Average
- 11.9M
- Vs 13W
- 0.2x
- Vs 52W
- 0.7x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 20.6%
- 52W Volatility
- 11.7%
- Upside Weeks
- 16
- Downside Weeks
- 36
- Downside Breadth
- 69.2%
- Avg Gain / Loss
- 10.1% / -6.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- KRW
- Market Cap
- 104.4B
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 918.0 KRW | -15.4% | 1,432 KRW | 2,416 KRW | 0.69 | -75.11 | 8.2M | Off |
| 5 Jun 2026 | 1,085 KRW | -3.3% | 1,476 KRW | 2,439 KRW | 0.67 | -71.71 | 32.7M | Off |
| 29 May 2026 | 1,122 KRW | -14.5% | 1,508 KRW | 2,464 KRW | 0.47 | -72.77 | 26.4M | Off |
| 22 May 2026 | 1,312 KRW | 36.7% | 1,541 KRW | 2,489 KRW | 0.10 | -67.09 | 141.9M | Off |
| 15 May 2026 | 960.0 KRW | -15.0% | 1,568 KRW | 2,513 KRW | -0.26 | -75.93 | 73.3M | Off |
| 8 May 2026 | 1,129 KRW | 30.5% | 1,608 KRW | 2,538 KRW | -0.43 | -72.43 | 12.4M | Off |
| 1 May 2026 | 865.0 KRW | -14.4% | 1,643 KRW | 2,566 KRW | -0.73 | -76.54 | 10.6M | Off |
| 24 Apr 2026 | 1,011 KRW | -0.6% | 1,689 KRW | 2,600 KRW | -0.94 | -72.71 | 99.1M | Off |
| 17 Apr 2026 | 1,017 KRW | 43.2% | 1,731 KRW | 2,632 KRW | -1.23 | -71.99 | 17.7M | Off |
| 10 Apr 2026 | 710.0 KRW | -18.2% | 1,777 KRW | 2,666 KRW | -1.55 | -79.77 | 16.1M | Off |
| 3 Apr 2026 | 868.0 KRW | -10.6% | 1,835 KRW | 2,705 KRW | -1.67 | -73.65 | 4.4M | Off |
| 27 Mar 2026 | 971.0 KRW | -6.3% | 1,888 KRW | 2,741 KRW | -1.59 | -71.44 | 12.4M | Off |
| 20 Mar 2026 | 1,036 KRW | -4.7% | 1,931 KRW | 2,775 KRW | -1.56 | -71.86 | 3.6M | Off |
| 13 Mar 2026 | 1,087 KRW | 0.3% | 1,971 KRW | 2,811 KRW | -1.52 | -69.45 | 3.2M | Off |